Panacea Biotec Ltd. benchmarking: Perfomance to industry peers

Financial

	Panacea Biotec	Indoco Remedies	Bliss GVS Pharma
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	6.0 .	54.0 .	n/a
R&D as a % of Total Sales	9.86 %	5.7 %	2.7 %
Financials
5 yr Average ROE	36.5 %	8.94 %	6.83 %
5yr average Equity Multiplier	0.36	1.9	1.3
5yr Average Asset Turnover Ratio	0.41	0.88	0.62
5yr Avg Net Profit Margin	26.1 %	5.41 %	8.7 %
Price to Book	2.71	1.99	1.62
P/E	0.0	0.0	16.72
5yr Avg Cash Conversion Cycle	-170.26 Days	35.3 Days	186.56 Days
Inventory Days	120.03 Days	70.6 Days	54.35 Days
Days Receivable	42.2 Days	83.16 Days	189.93 Days
Days Payable	325.14 Days	111.01 Days	75.78 Days
5yr Average Interest Coverage Ratio	2.7	7.53	14.68
5yr Avg ROCE	-2.79 %	13.6 %	13.27 %
5yr Avg Operating Profit Margin	-3.85 %	14.97 %	17.03 %
5 yr average Debt to Equity	-0.69	0.49	0.11
5yr CAGR Net Profit	-43.68 %	n/a	4.24 %
5yr Average Return on Assets	9.32 %	5.31 %	5.31 %
Shareholdings
Promoter Holding	72.48 %	58.9 %	35.36 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-1.11 %	0.21 %	0.9 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.27 %	0.0

Business

	Panacea Biotec	Indoco Remedies	Bliss GVS Pharma
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti - Diabetes 43.91 Gastro Intestinal 13.47 Pain Management 12.87 Anti-Neoplastics 8.18 Vitamins / Minerals / Nutrients 6.09 Respiratory Systems 5.39 Vaccines 5.39 Blood Related 2.99 Hormones 0.6 Cardiac 0 Urological 0 Dermatology 0 Gynaecology 0 Pain / Analgesics 0 Ophthal / Otologicals 0 Vitamins / Minerals / Nutrients 0 Anti-Infectives 0 Stomatologicals 0 Others 1.11	Therapeutic Area Wise Break-Up - Domestic Vitamins / Minerals / Nutrients 9.07 Hormones 0 Ophthalmology 5.88 Respiratory Systems 0 Stomatologicals 13.47 Gastro Intestinal 18.13 Vaccines 0 Cardiac Science 3.12 Pain Management 3.41 Gynecology 1.17 Anti - Diabetes 0 Urology 8.44 Anti-Infective 15.18 Blood Related 0 Anti-Neoplastics 0 Pain Management 0 Dermatology 5.05 Others 17.08	-
Product Wise Break-Up	Product Wise Break-Up Vaccines 64.34 Formulations 35.66 Research and Development 0 CRO, Analytical Services 0 API 0 Formulation 0 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0	Product Wise Break-Up Research and Development 0 Vaccines 0 Active Pharmaceutical Ingredient (API) 9.0 Anti Inflammatory 0 Anti-biotic 0 Antimalarial 0 Anti-fungal, 0 Anti-bacterial 0 Formulations 0 CRO, Analytical Services 1.0 Formulations 90.0	Product Wise Break-Up Research and Development 0 Vaccines 0 API 0 Anti Inflammatory 7.0 Antibiotics 5.0 Anti Malarials 43.0 Anti-fungal 16.0 Anti-bacterial 0 Formulations 0 CRO, Analytical Services 0 Formulation 0 Others 29.0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 86.09 India 13.91	Location Wise Break-Up India 64.37 Rest of the World 35.63	Location Wise Break-Up India 6.61 Rest of the World 93.39
Operating Profit Break-Up	Operating Profit Break-Up Others 100	-	-
Capex	Capex Vaccines 69.46 Formulations 30.54 Real estate 0	-	-
Brand Wise Break-Up	Brand Wise Break-Up PanGraf 21.0 Glizid Family 19.0 Sitcom Family 10.0 Mycept & Mycept 5.0 Livoluk Family 4.0 Panimun Bioral 4.0 PacliAll 1.0 Thank OD Family 0 Nimulid Family 0 Others 36.0	-	-
Asset Break-Up	Asset Break-Up Vaccines 69.42 Formulations 30.58 Real Estate 0	-	-

Panacea Biotec Ltd.

Panacea Biotec Ltd.

Financial

Business

SIGN UP FOR FREE